Also listed as: Hair growth - excessive
Hirsutism is excessive growth of dark, coarse body and facial hair in women. The abnormal hair growth typically occurs in a pattern seen in adult males. While some body and facial hair growth is normal, women with hirsutism tend to produce elevated levels of male sex hormones called androgens from their ovaries and adrenal glands. Most cases of hirsutism are not excessive and have no underlying cause, but some may indicate the presence of a more serious underlying condition, such as Cushing's syndrome. An estimated 8% of adult women in the United States have hirsutism.
The primary signs and symptoms of hirsutism include:
Identifiable causes of hirsutism are generally related to increased secretion of androgens from the ovaries or adrenal glands. This can result from a variety of conditions, including:
Hirsutism may also be caused by:
The following factors may increase an individual's risk of hirsutism:
The first step is to conduct a physical examination. During the physical exam, the doctor will inspect the body for all sites of abnormal hair growth and ask questions about the onset and progression of the condition. A doctor may also perform a pelvic examination to determine whether tumors or cysts are present on the ovaries. After performing the physical examination, one of the following may be necessary to identify the cause of hirsutism:
Even if an individual is at risk for hirsutism, there are steps she can take to prevent it. For example, studies suggest that obese women with PCOS may be less likely to develop hirsutism if they consume a low-calorie diet.
The specific treatment for hirsutism depends on the extent of the problem, whether or not an underlying cause can be identified, and, if so, what the root of that cause is. For example, an individual with hirsutism will usually be advised to discontinue medications that may be contributing to the condition. If a tumor is located on the ovaries or adrenal glands, the doctor will likely recommend that it be surgically removed. Overweight individuals with hirsutism may be urged to participate in a weight loss program since calorie restriction may lower androgen production in the body. Although no medications for hirsutism have been approved by the U.S. Food and Drug Administration (FDA), some drugs may suppress androgen secretion and reduce hair growth. If no underlying cause that can be treated by conventional medication is identified, it may be possible to control the symptoms of hirsutism with acupuncture, and cosmetic therapies that conceal or remove excess hair (such as bleaching and waxing). Psychological support may also be helpful since hirsutism is often a frustrating and embarrassing condition.
|
Eating a balanced diet and getting adequate exercise can help control weight, which may diminish or prevent hirsutism related to obesity.
|
While there are currently no medications approved by the FDA specifically for the treatment of hirsutism, certain medications may be used to suppress the production and secretion of androgens in the body. Up to 70% of individuals with hirsutism may respond to these medications, but it can take 6 months or longer for the medications to effectively reduce hair growth and they must be taken indefinitely to keep the symptoms under control. These medications include:
|
A doctor may recommend the following surgical procedures in severe cases of hirsutism:
|
A comprehensive treatment plan for hirsutism may include a range of complementary and alternative therapies. Preliminary studies suggest that nutritional supplements may reduce the symptoms of some hirsutism. Ask your team of health care providers about the best ways to incorporate these therapies into your overall treatment plan. Always tell your health care provider about the herbs and supplements you are using or considering using.
Following these nutritional tips may help reduce symptoms:
You may address nutritional deficiencies with the following supplements:
|
Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should work with your health care provider to get your problem diagnosed before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, you should make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted. Talk with your health care provider about which herb may be best for you.
|
One small study of women with hirsutism found that acupuncture markedly reduced both hair density and hair length and significantly reduced their levels of the male sex hormone testosterone (a type of androgen). This study is promising, but further research will be required to determine whether greater numbers of women with hirsutism would benefit from acupuncture and what causes of hirsutism respond best to acupuncture.
|
|
If the underlying cause of hirsutism can be identified and treated, the symptoms of hirsutism may be effectively controlled. Long-term medication, when appropriate, will slow hair growth, but it generally won't eliminate existing hair patterns on the face and body. There are some cosmetic therapies that can reduce the appearance of excessive hair growth. Counseling with a trained professional may also be helpful for women who experience psychological stress as a result of their hair growth.
Agnusdei D, Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int 199:61:S23–7.
Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacol . 2003;18(3):191-5.
Botwood N, Hamilton-Fairley D, Kiddy D, Robinson S, Franks S. Sex hormone-binding globulin and female reproductive function . J Steroid Biochem Mol Biol. 1995;53(1-6):529-531.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea--a review. J Am Coll Nutr . 2006;25(2):79-99.
Crave JC, Fimbel S, LeJeune H, Cugnardey N, Dechaud H, Pugeat M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab. 1995;80(7):2057-2062.
Dambro MR, ed. Griffith's 5 Minute Clinical Consult . Baltimore, Md: Lippincott Williams & Wilkins, Inc.; 1999.
Derksen J, Nagesser SK, Meinders AE, Haak HR, van de Velde CJ. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med . 1994;331(15):968-973.
Dierickx C, Alora MB, Dover JS. A clinical overview of hair removal using lasers and light sources. Dermatol Clin . 1999;17(2):357-366.
El-Sheikh MM, Dakkak MR, Saddique A. The effect of Permixon on androgen receptors. Acta Obstet Gynecol Scand . 1988;67(5):397-399.
Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine . 14th ed. New York, NY: McGraw-Hill; 1998.
Goldman L, Bennett JC, eds. Cecil Textbook of Medicine . 21st ed. Philadelphia, Pa: W.B. Saunders; 2000.
Goroll AH, ed. Primary Care Medicine . 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1995.
Habif TP. Clinical Dermatology . 3rd ed. St. Louis, Mo: Mosby-Year Book; 1996.
Heerdt AS, Young CW, Borgen PI. Calcium glucarate as a chemopreventive agent in breast cancer. Isr J Med Sci . 1995;31(2-3):101-5.
Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36(1):105-111.
Middlekauff HR, Yu JL, Kui K. Acupuncture effects on reflex responses to mental stress in humans. Am J Physiol Regulat Integrat Comp Physiol . 2001;280:R1462-R1468.
Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med . 1996;335(9):617-623.
[No authors listed]. Rhodiola rosea. Monograph. Altern Med Rev . 2002;7(5):421-3.
Pandi-Perumal SR, Srinivasan V, Maestroni GJ, et al., Melatonin. FEBS J . 2006;273(13):2813-38.
Pasquali R, Antenucci D, Casimirri F, et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab . 1989 Jan;68(1):173-179.
Rai D, Bhatia G, Sen T, Palit G. Anti-stress effects of Ginkgo biloba and Panax ginseng: a comparative study. J Pharmacol Sci . 2003;93(4):458-64.
Rogan EG. The natural chemopreventive compound indole-3-carbinol: state of the science. In Vivo . 2006;20(2):221-8.
Rotsein OD. Oxidants and antioxidant therapy. Crit Care Clin . 2001;17(1):239-47.
Rittmaster RS. Medical treatment of androgen-dependent hirsutism. J Clin Endrocrinol Metab . 1995;80(9):2559-2563.
Ryan KJ, ed. Kistner's Gynecology and Women's Health . 7th ed. St. Louis, Mo: Mosby, Inc.; 1999.
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr . 2002;21(6):495-505.
Sultan C, Terraza A, Devillier C, et al. Inhibition of androgen metabolism and binding by a liposterolic extract of " Serenoa repens B" in human foreskin fibroblasts. J Steroid Biochem . 1984;20(1):515-519.
Ullman D. The Consumer's Guide to Homeopathy . New York, NY: Putnam Publishing Group; 1995.
Wilson JD, ed. Williams Textbook of Endocrinology . 9th ed. Philadelphia, Pa: W.B. Saunders; 1998.
Wu ZS, Cai XA. Acupuncture treatment of hirsutism and its effect on the endocrinosity. J Tradit Chin Med. 1989;9(3):207-209.
Wuttke W, Gorkow C, Seidlova-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause . 2006;13(2):185-96.
Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlove-Wuttke D. Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications. Phytomedicine . 2003;10(4):348-57.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J . 2005;46(5):585-96.
Young R, Sinclair R. Hirsutes. I: Diagnosis. Australas J Dermatol . 1998;39(1):24-28.
Young R, Sinclair R. Hirsutes. II: Treatment. Australas J Dermatol . 1998;39(3):151-157.
Zuckerman-Levin N, Tiosano D, Eisenhofer G, et al. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab . 2001;86(12):5920-4
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |